MultivisionDx

Private

HelsinkiHealthcare & Life Scienceshttps://multivision.ai/

Last Round

Pre Seed

Dec 3, 2025

Total Funding Raised

$1.87M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

MultivisionDx is a biotechnology company that develops AI-powered decision-support tools for personalized diagnosis and treatment selection for solid cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

spatial biologydigital pathologycancer diagnosticsprecision medicinein vitro diagnosticsIVDclinical decision supportbiomarker discoveryspatial transcriptomicscomputer visiononcology AImultiplexed imagingresearch use onlyRUOAI pathology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MultivisionDx Comps

Public and private peers based on sector, stage, and business model.

MultivisionDx comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MultivisionDx Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Pre Seed	Dec 3, 2025
Grant	Nov 1, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Karolina Punovuori

Co-Founder & Chief Scientific Officer

Founding Team

Michael Wittinger

Chief Executive Officer

Executive Team

MultivisionDx Investors

Notable investors and investment history

MultivisionDx investors
Investor	Rounds
Helsinki University Funds	Pre Seed
Business Finland	Grant
Antler	Pre Seed
Kaikarhenni Oy	Pre Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Dec 3, 2025
$1.18M raised in Pre Seed round.
Nov 1, 2022
$690K grant received from Business Finland

View all signals

MultivisionDx Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

MultivisionDx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MultivisionDx's valuation, stock price, and market status.

Firmographic Details

HeadquartersHelsinki

Employee Range4

Year Founded2025

Last FundingDec 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.